EYNSHAM MEDICAL GROUP — All Prescriptions & Medications — Page 14
Practice Code: K84006 | WITNEY, OX29 4QB
Showing results 651-700 of 710
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Hepatitis A/hepatitis B | 13 | 13 | £385 | -23.1% ▼ |
| 13 | 17 | £507 | +43.3% ▲ | |
| 13 | 32 | £285 | +82.5% ▲ | |
| 13 | 320 | £135 | -37.6% ▼ | |
| 13 | 1,010 | £213 | -52.4% ▼ | |
| 13 | 2,700 | £362 | -41.9% ▼ | |
| 13 | 520 | £2.6K | +38.3% ▲ | |
| 13 | 390 | £224 | +22.2% ▲ | |
| 13 | 930 | £1.8K | +23.7% ▲ | |
| 13 | 195 | £848 | +62.3% ▲ | |
| Chlortalidone | 12 | 360 | £673 | +21.7% ▲ |
| Glycopyrronium bromide | 12 | 360 | £314 | -67.8% ▼ |
| Lithium citrate | 12 | 3,450 | £118 | +33.5% ▲ |
| Disulfiram | 12 | 168 | £575 | -19.0% ▼ |
| Erythromycin ethylsuccinate | 12 | 2,456 | £298 | -48.6% ▼ |
| Mebendazole | 12 | 243 | £18 | +4.8% ▲ |
| Tacrolimus | 12 | 1,200 | £1.3K | -55.1% ▼ |
| Ready to serve 50% MCT liquid (0913181) | 12 | 56.0K | £3.1K | +76.7% ▲ |
| Atropine sulfate | 12 | 150 | £1.6K | -5.8% ▼ |
| Heparinoid | 12 | 1,500 | £113 | -8.0% ▼ |
| 12 | 22 | £102 | -70.5% ▼ | |
| 12 | 450 | £2.1K | +44.5% ▲ | |
| 12 | 1,420 | £287 | +15.3% ▲ | |
| Olmesartan medoxomil/amlodipine | 11 | 308 | £177 | -16.6% ▼ |
| Omega-3-acid ethyl esters | 11 | 1,232 | £595 | -47.9% ▼ |
| Bempedoic acid | 11 | 308 | £579 | -66.4% ▼ |
| Acrivastine | 11 | 736 | £208 | -10.7% ▼ |
| Propylthiouracil | 11 | 356 | £32 | -12.5% ▼ |
| Hydrocortisone sodium succinate | 11 | 12 | £13 | +188.8% ▲ |
| Lanreotide | 11 | 11 | £10.3K | +19.3% ▲ |
| Specialist food replacer 3:1 savoury biscuit (0913181) | 11 | 4,620 | £289 | +128.4% ▲ |
| Betaxolol | 11 | 550 | £135 | +15.7% ▲ |
| Triamcinolone acetonide | 11 | 11 | £75 | +7.4% ▲ |
| Co-cyprindiol (Cyprote acetate/ethinylestradiol) | 11 | 693 | £65 | +26.8% ▲ |
| Salicylic acid | 11 | 111 | £40 | -13.0% ▼ |
| 11 | 186 | £484 | +66.0% ▲ | |
| 11 | 378 | £102 | -67.0% ▼ | |
| 11 | 16 | £1.2K | +10.3% ▲ | |
| 11 | 12 | £738 | +26.3% ▲ | |
| 11 | 330 | £1.2K | +36.2% ▲ | |
| 11 | 660 | £1.1K | +80.2% ▲ | |
| Levocetirizine | 10 | 300 | £39 | -35.8% ▼ |
| Riluzole | 10 | 560 | £3.0K | -3.6% ▼ |
| Alendronic acid/colecalciferol | 10 | 40 | £211 | +30.3% ▲ |
| Metronidazole | 10 | 440 | £45 | +51.2% ▲ |
| Oral rehydration salts | 10 | 148 | £62 | -65.4% ▼ |
| Ready to serve 1 - 1.3 kcal/ml m/sk lower energy (0913011) | 10 | 75.0K | £999 | +43.5% ▲ |
| RtS extensively hydrolysed formula, high energy (0913103) | 10 | 136.8K | £3.4K | +74.7% ▲ |
| Ready to serve 4.5 - 5 kcal/ml energy (fat) liquid (0913142) | 10 | 4,000 | £134 | -10.8% ▼ |
| Fludroxycortide | 10 | 20 | £431 | -5.2% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.